Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Account Payables (2021 - 2025)

Historic Change in Account Payables for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to -$1.2 million.

  • Core Scientific's Change in Account Payables fell 67437.5% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 million, marking a year-over-year decrease of 12449.66%. This contributed to the annual value of -$12.3 million for FY2024, which is 11032.03% down from last year.
  • Latest data reveals that Core Scientific reported Change in Account Payables of -$1.2 million as of Q3 2025, which was down 67437.5% from -$2.1 million recorded in Q2 2025.
  • Core Scientific's 5-year Change in Account Payables high stood at $86.1 million for Q4 2023, and its period low was -$39.0 million during Q3 2021.
  • For the 5-year period, Core Scientific's Change in Account Payables averaged around $4.9 million, with its median value being -$632000.0 (2024).
  • In the last 5 years, Core Scientific's Change in Account Payables soared by 87021.1% in 2023 and then tumbled by 67437.5% in 2025.
  • Quarter analysis of 5 years shows Core Scientific's Change in Account Payables stood at $13.1 million in 2021, then soared by 80.8% to $23.8 million in 2022, then soared by 262.56% to $86.1 million in 2023, then plummeted by 100.73% to -$632000.0 in 2024, then tumbled by 96.04% to -$1.2 million in 2025.
  • Its Change in Account Payables stands at -$1.2 million for Q3 2025, versus -$2.1 million for Q2 2025 and -$14.3 million for Q1 2025.